BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16153607)

  • 1. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro.
    Ono K; Hirohata M; Yamada M
    Biochem Biophys Res Commun; 2005 Oct; 336(2):444-9. PubMed ID: 16153607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Naiki H; Yamada M
    J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro.
    Ono K; Hasegawa K; Naiki H; Yamada M
    Biochem Biophys Res Commun; 2005 Apr; 330(1):111-6. PubMed ID: 15781239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro.
    Ono K; Hirohata M; Yamada M
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1046-52. PubMed ID: 16460684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Naiki H; Yamada M
    Neurochem Int; 2006 Mar; 48(4):275-85. PubMed ID: 16343694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro.
    Morinaga A; Hirohata M; Ono K; Yamada M
    Biochem Biophys Res Commun; 2007 Aug; 359(3):697-702. PubMed ID: 17559807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Naiki H; Yamada M
    Biochim Biophys Acta; 2004 Nov; 1690(3):193-202. PubMed ID: 15511626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
    Hirohata M; Ono K; Naiki H; Yamada M
    Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro.
    Ono K; Noguchi-Shinohara M; Samuraki M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
    Exp Neurol; 2006 Nov; 202(1):125-32. PubMed ID: 16806179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro.
    Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
    Exp Neurol; 2004 Oct; 189(2):380-92. PubMed ID: 15380488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
    Ono K; Yamada M
    J Neurochem; 2006 Apr; 97(1):105-15. PubMed ID: 16524383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro.
    Ono K; Noguchi M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
    Neurobiol Dis; 2005 Nov; 20(2):233-40. PubMed ID: 16242632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure.
    Hirohata M; Hasegawa K; Tsutsumi-Yasuhara S; Ohhashi Y; Ookoshi T; Ono K; Yamada M; Naiki H
    Biochemistry; 2007 Feb; 46(7):1888-99. PubMed ID: 17253770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Yoshiike Y; Takashima A; Yamada M; Naiki H
    J Neurochem; 2002 May; 81(3):434-40. PubMed ID: 12065652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dendrimer's structure on its activity against amyloid fibril formation.
    Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M
    Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's beta-amyloid proteins.
    Fujiwara H; Iwasaki K; Furukawa K; Seki T; He M; Maruyama M; Tomita N; Kudo Y; Higuchi M; Saido TC; Maeda S; Takashima A; Hara M; Ohizumi Y; Arai H
    J Neurosci Res; 2006 Aug; 84(2):427-33. PubMed ID: 16676329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective destabilization of soluble amyloid beta oligomers by divalent metal ions.
    Garai K; Sengupta P; Sahoo B; Maiti S
    Biochem Biophys Res Commun; 2006 Jun; 345(1):210-5. PubMed ID: 16678130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.
    Ono K; Hirohata M; Yamada M
    J Neurosci Res; 2007 May; 85(7):1547-57. PubMed ID: 17387689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.